HCA Healthcare Inc $ 81.83 -2.07 (-2.47%)
Volume:
2,080,765
Avg Vol (1m):
3,245,070
Market Cap $:
27.70 Bil
Enterprise Value $:
64.89 Bil
P/E (TTM):
8.13
P/B:
0.00
Financial Strength | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.02 | ||
| Equity-to-Asset | -0.06 | ||
| Debt-to-Equity | -12.67 | ||
| Debt-to-EBITDA | 3.68 | ||
| Interest Coverage | 3.96 | ||
| Piotroski F-Score | 8 | ||
| Altman Z-Score | 2.05 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 14.06 | ||
| Net Margin % | 6.83 | ||
| ROA % | 8.08 | ||
| ROC (Joel Greenblatt) % | 26.95 | ||
| 3-Year Revenue Growth Rate | 12 | ||
| 3-Year EBITDA Growth Rate | 9 | ||
| 3-Year EPS without NRI Growth Rate | 11.3 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 8.13 | ||
| Forward PE Ratio | 6.99 | ||
| PE Ratio without NRI | 8.13 | ||
| Price-to-Owner-Earnings | 8.23 | ||
| PS Ratio | 0.56 | ||
| Price-to-Free-Cash-Flow | 8.26 | ||
| Price-to-Operating-Cash-Flow | 3.76 | ||
| EV-to-EBIT | 9.19 | ||
| EV-to-EBITDA | 6.7 | ||
| EV-to-Revenue | 1.28 | ||
| PEG Ratio | 0.67 | ||
| Shiller PE Ratio | 13.27 | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.2 | ||
| Days Inventory | 20.4 | ||
| Days Sales Outstanding | 52.47 | ||
| Days Payable | 33.09 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 1.99 | ||
| Dividend Payout Ratio | 0.16 | ||
| Forward Dividend Yield % | 2.1 | ||
| 5-Year Yield-on-Cost % | 2.01 | ||
| 3-Year Average Share Buyback Ratio | 2.9 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.76 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 0.41 | ||
| Price-to-Peter-Lynch-Fair-Value | 0.65 | ||
| Earnings Yield (Greenblatt) % | 10.91 | ||
| Forward Rate of Return (Yacktman) % | 21.63 |